Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Mohr

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Psychology|March 20, 2001
Multiple sclerosis: empirical literature for the clinical health psychologistD C Mohr, D Cox
Psychological Medicine|July 21, 2004
The relationship between social support, depression and treatment for depression in people with multiple sclerosisD C Mohr, C Classen, M Barrera
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosisL Julian, N M Merluzzi, D C Mohr
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Screening for depression among patients with multiple sclerosis: two questions may be enoughD C Mohr, S L Hart, L Julian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2006
Treatment of depression for patients with multiple sclerosis in neurology clinicsD C Mohr, S L Hart, I Fonareva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
Depression, coping and level of neurological impairment in multiple sclerosisD C Mohr, D E Goodkin, N Gatto, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectD C Mohr, A C Boudewyn, W Likosky, et al.
Journal of Consulting and Clinical Psychology|January 5, 2002
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosisD C Mohr, A C Boudewyn, D E Goodkin, et al.
Psychological Medicine|May 18, 2013
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?M N Burns, E Nawacki, M J Kwasny, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2004
Peer support groups in multiple sclerosis: current effectiveness and future directionsM Messmer Uccelli, L Mancuso Mohr, M A Battaglia, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Psychology|March 20, 2001
Multiple sclerosis: empirical literature for the clinical health psychologistD C Mohr, D Cox
Psychological Medicine|July 21, 2004
The relationship between social support, depression and treatment for depression in people with multiple sclerosisD C Mohr, C Classen, M Barrera
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosisL Julian, N M Merluzzi, D C Mohr
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Screening for depression among patients with multiple sclerosis: two questions may be enoughD C Mohr, S L Hart, L Julian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2006
Treatment of depression for patients with multiple sclerosis in neurology clinicsD C Mohr, S L Hart, I Fonareva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
Depression, coping and level of neurological impairment in multiple sclerosisD C Mohr, D E Goodkin, N Gatto, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectD C Mohr, A C Boudewyn, W Likosky, et al.
Journal of Consulting and Clinical Psychology|January 5, 2002
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosisD C Mohr, A C Boudewyn, D E Goodkin, et al.
Psychological Medicine|May 18, 2013
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?M N Burns, E Nawacki, M J Kwasny, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2004
Peer support groups in multiple sclerosis: current effectiveness and future directionsM Messmer Uccelli, L Mancuso Mohr, M A Battaglia, et al.
Pageof 4